Godsey & Gibb Inc’s Colgate-Palmolive CL Stock Holding History

Godsey & Gibb Inc’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-225	Closed	-$17K	–	106
2021 Q3	$17K	Buy	+225	New	+$17.9K	0.01%	64

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Godsey & Gibb Inc's CL Position: Q4 2021 in Review

Godsey & Gibb Inc sold out of Colgate-Palmolive (CL) in Q4 2021, closing a stake of 225 shares — an estimated $17K sold.

Godsey & Gibb Inc first reported a position in CL in Q3 2021 and held it in 1 quarter. The position peaked at $17K in Q3 2021. 1,704 funds tracked by Wall St. Rank hold CL as of Q4 2021.

Godsey & Gibb Inc reported no remaining Colgate-Palmolive position as of Q4 2021 after selling out during the quarter.
Godsey & Gibb Inc sold 225 Colgate-Palmolive shares in Q4 2021, an estimated $17K.
Godsey & Gibb Inc first reported a position in Colgate-Palmolive in Q3 2021 and held it in 1 quarter.
Godsey & Gibb Inc's Colgate-Palmolive position peaked at $17K in Q3 2021.
1,704 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2021.

Based on Godsey & Gibb Inc's 13F filing for Q4 2021, filed 15 Feb 2022.